Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of LAM-003 in Patients With Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03426605
Recruitment Status : Recruiting
First Posted : February 8, 2018
Last Update Posted : December 11, 2018
Sponsor:
Information provided by (Responsible Party):
AI Therapeutics, Inc (formerly known as LAM Therapeutics, Inc.)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : January 2020